secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biohaven Ltd. (BHVN)
CIK:        0001935979
Form:       8-K
Filed at:   2026-07-09T21:11:27+00:00
Accession:  0001935979-26-000053
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biohaven CSO Bruce Car retires to part-time Chief Innovation Officer; Pirman promoted to EVP Discovery
--------------------------------------------------------------------------------

- Bruce Car retires as CSO, becomes part-time Chief Innovation Officer effective July 13, 2026, focusing on external collaborations including Bexorg.
- David Pirman promoted to EVP and Head of Discovery, leading internal drug-discovery organization.
- Warren Volles, General Counsel and Chief Legal Officer, designated an executive officer.
- Dr. Car's salary reduced by 50% to reflect part-time work schedule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1935979/000193597926000053/0001935979-26-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1935979/000193597926000053/bhvn-20260709.htm
  HTML page:      https://secwatch.observer/filing/0001935979-26-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer